In This Article:
For some energy investors, last week was a great one after a quartet of stocks in the sector rallied sharply on some bullish news. That likely had those on the outside looking in wondering whether they missed the boat, or if there might be more upside ahead. Here's a closer look at what fueled this week's big move in those energy stocks and whether they have anything left in the tank.
Trump rumors fueled bullish buying in these refining stocks
Shares of refining companies Andeavor (NYSE: ANDV) and CVR Refining (NYSE: CVRR) took off this week, rallying about 11% each. Fueling those moves was increasing speculation that the White House will make changes to the U.S. Renewable Fuel Standards program, which is a crucial issue impacting smaller refiners. That program requires refiners to mix biofuels like corn-based ethanol into their fuel to help farmers and reduce the country's oil imports. However, it has become increasingly costly for smaller refiners like Andeavor and CVR Refining because the price of purchasing tradable blending credits, known as RINs, has skyrocketed in recent years.
Image source: Getty Images.
The Trump administration has been working with both refiners and corn producers on a solution that addresses this issue and has another high-level meeting scheduled for next week. If the two sides can agree on a solution, it could dramatically reduce costs for companies like CVR Refining and Andeavor. CVR Refining, for example, believes a policy change could save it $50 million this year and cut its compliance costs down to $200 million. That said, there are no guarantees that the two sides will reach an agreement, which means last week's big gains could go up in smoke.
Finally turning around, but still a long way to go
Two other big movers this week were specialty petroleum products maker Calumet Specialty Products Partners (NASDAQ: CLMT) and Canadian oil producer Baytex Energy (NYSE: BTE), which surged 15% and nearly 20%, respectively, this week after reporting fourth-quarter results. In Calumet Specialty's case, its adjusted EBITDA more than tripled to $60.1 million. Because of that, and some asset sales, the company has significantly improved its credit profile in the past year, reducing its leverage ratio from a gravely concerning 13 times debt-to-adjusted EBITDA in 2016 to less than five times this year. That led the company's CEO Tim Go to proclaim that he was "pleased to report that we have successfully turned the corner." While Calumet is heading in the right direction, it remains a riskier investment option.